Moolec Science SA (NASDAQ:MLEC) Short Interest Down 52.1% in July

Moolec Science SA (NASDAQ:MLEC) was the target of a significant drop in short interest in the month of July. As of July 31st, there was short interest totaling 4,512 shares, a drop of 52.1% from the July 15th total of 9,414 shares. Approximately 0.8% of the company’s stock are sold short. Based on an average daily trading volume, of 18,186 shares, the short-interest ratio is presently 0.2 days.

Institutional Investors Weigh In On Moolec Science

A hedge fund recently bought a new stake in Moolec Science stock. Citadel Advisors LLC purchased a new stake in Moolec Science SA (NASDAQ:MLEC) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned approximately 0.90% of Moolec Science as of its most recent filing with the SEC. 0.07% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised Moolec Science from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th.

Moolec Science Stock Up 19.0%

Moolec Science stock traded up $1.37 during trading hours on Monday, hitting $8.57. The company had a trading volume of 83,300 shares, compared to its average volume of 641,358. The firm has a market capitalization of $6.26 million, a P/E ratio of -0.26 and a beta of 0.26. The company has a debt-to-equity ratio of 0.79, a current ratio of 0.15 and a quick ratio of 0.08. The firm’s fifty day moving average is $7.39 and its 200-day moving average is $8.15. Moolec Science has a fifty-two week low of $3.08 and a fifty-two week high of $38.55.

Moolec Science (NASDAQ:MLEC) last issued its earnings results on Thursday, May 14th. The company reported $47.49 earnings per share (EPS) for the quarter. The company had revenue of $2.62 million for the quarter.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.